Innovating in health: how an award-winning Argentine laboratory works in the United States

The advance of the medicine it requires both professionals and health companies that are concerned with creating and expanding new solutions for people. Under this premise works gadora high tech lab originally 100% national.

This pharmaceutical company was founded in 1940 by Nicolas Gador as a distributor of Hungarian products, in the City of Buenos Aires. Eight years later, Américo and Jorge Balla (of the same nationality) joined, who positioned Gador as an industrial laboratory and whose families are still part of the board of directors.

Dedicated to the research, manufacture and marketing of medicines, it currently has four large facilities state-of-the-art technology: an oral solids plant in Villa Crespo, CABA; pharmachemical, hormonal and high potency active plants in Pilar, province of Buenos Aires; a plant in Catamarca and even another in Montevideo, Uruguay.

With 1,300 collaborators in Latin America and close to 1,100 of them in Argentinahas seven subsidiaries in Chile, Uruguay, Brazil, Peru, Ecuador, Colombia and Paraguay and is present in 40 countries around the world through its own subsidiaries, distributors or technology transfer to strategic partners.

Its most important product portfolio is in Argentina, with clinical and scientific experience in twenty therapeutic areas. Among these, her work on the central nervous system, cardiometabolism, line of hormones that accompanies women in all stages of their lives and special treatments for rare pathologies stand out.

One of the important developments of the company is the case of the triple therapy for the cystic fibrosisa genetic disease suffered by about 1,500 people in the country. gador is he first Argentine laboratory in advancing with a national treatment to improve the quality of life of those who suffer from this pathology.

“Our commitment to local research and development is key to sustained growth. Every day we work to develop new products and venture into different therapeutic areas so that patients can have accessible medicines”, explains Alfredo Weber, general director of Gador.

According to company data, during the last five years registered a growth of 17.5% in units sold -nearly 3,500,000 medications per month-. So he became the second laboratory in the country in the prescription drug market.

The constant investment in infrastructure, research and development was key for Gador when it came to accompanying the growth of the national industry. In this way, continuing to innovate in Emerging technologies led the company to develop raw materials, venture into new therapeutic areas and even find alternative uses for existing molecules.

In that sense, the laboratory received -together with a CONICET research team- an award from the American Heart Association for the study of a possible solution for prevent and treat preeclampsiaa type of hypertension in pregnancy that still has no treatment or preventive method.

Currently, the company has licenses from thirteen companies around the world that allow you market its medicines in Argentina and in the rest of Latin America.

“Our medicines are produced and distributed with cutting-edge technologies and the highest international quality standards for Argentina and the world. The motto ‘Caring for life’ synthesizes our commitment to the health and well-being of the community”, concludes Weber.

For more information, you can visit the official website of gador or to their official accounts instagram Y Facebook.